天宇股份:公司2025年全年归母净利润同比实现大幅增长

Core Viewpoint - Tianyu Co., Ltd. expects a significant year-on-year increase in net profit attributable to shareholders for the full year of 2025, indicating a stable operational foundation despite challenges in the fourth quarter [2] Group 1: Financial Performance - The company reported a decline in gross profit margin in the fourth quarter due to changes in product sales structure, increased costs, and asset impairment provisions [2] - Expenses have increased, contributing to a reduction in overall profit for the fourth quarter compared to the previous periods [2] Group 2: Future Outlook - The company advises stakeholders to refer to the upcoming 2025 Annual Report for detailed financial disclosures and performance metrics [2]

Zhejiang Tianyu Pharmaceutical -天宇股份:公司2025年全年归母净利润同比实现大幅增长 - Reportify